Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer
Recruiting · NCT05744687 · Registry updated 2025-08-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase II/III Study of SPH4336 Combined With Letrozole vs Placebo Combined With Letrozole in First-line Treatment of Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 / Phase 3 | 2025-08-17 | NCT05744687 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Pharmaceuticals Holding Co., Ltd | 20 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Cancer Hospital, Sun Yat-sen University | Guangzhou | China | 3 |
| Anyang Tumor Hospital | Anyang | China | 10 |
| Fujian Cancer Hospital | Fuzhou | China | 109 |
| General Hospital of Ningxia Medical University | Yinchuan | China | 7 |
| Peking University Cancer Hospital | Beijing | China | 11 |
| Pingxiang People's Hospital | Pingxiang | China | 2 |
| The Affiliated Cancer Hospital of Guizhou Medical University | Guiyang | China | 3 |
| The First Affiliated Hospital of Henan University of science and Technology | Luoyang | China | 5 |
| The Second Norman Bethune Hospital of Jilin Univer | Changchun | China | 1 |